Search

Your search keyword '"Schmutzler, Rita Katharina"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Schmutzler, Rita Katharina" Remove constraint Author: "Schmutzler, Rita Katharina"
171 results on '"Schmutzler, Rita Katharina"'

Search Results

1. First international workshop of the ATM and cancer risk group (4-5 December 2019)

2. Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks

3. Implementing mainstream genetic counseling within the area‐wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GD‐HBOC): Satisfaction of primary care providers with the provided state‐of‐the‐art training by the Cologne Center

5. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

6. Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

8. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

9. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

10. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

11. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

12. Implementierung und Evaluation eines Decision Coaching Programms für gesunde BRCA1/2 Mutationsträgerinnen - Ergebnisse der randomisierten kontrollierten EDCP-BRCA

15. Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire

16. Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire

18. Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer

19. First international workshop of the ATM and cancer risk group (4-5 December 2019)

21. Quality and Quantity: How to Organize a Countrywide Genetic Counseling and Testing

22. Breast Cancer Risk in Familial CHEK2 Germline Mutation Carriers is Modified by the Polygenic Risk Score: A Multicenter Study by the German Consortium for Hereditary Breast and Ovarian Cancer

25. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

26. Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort

27. Gezielte Früherkennung und risikoadaptierte Therapie

28. Interdisziplinäre Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Registernummer 032/045OL, Dezember 2017) – Teil 1 mit Empfehlungen zur Früherkennung, Diagnostik und Nachsorge des Mammakarzinoms

29. Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort

30. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

31. Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

32. Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer : guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, December 2017) – part 1 with recommendations for the screening, diagnosis and therapy of breast cancer

33. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

34. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

35. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

36. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

37. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression

38. Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

39. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

40. Consensus Recommendation of the German Consortium Family Breast and Ovarian Cancer for dealing with Results of the Multigenic Analysis

41. Use of the BOADICEA breast cancer risk prediction tool in clinical practice: appraisals across clinicians from various countries.

42. Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

43. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

44. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

45. The first targeted therapy in ovarian cancer permitted for BRCA1/2 mutation carriers

46. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

47. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

48. Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers

Catalog

Books, media, physical & digital resources